Diabetes Care
(ISSN: 0149-5882)
Show only: Full-text on Medscape
2009 - 32 (7)
- Counterpoint: Selective screening for gestational diabetes mellitus.
- Point: Universal screening for gestational diabetes mellitus.
- Multiple biomarker prediction of type 2 diabetes.
- Redefining the diagnosis of diabetes using glycated hemoglobin.
- Hyperglycemic crises in adult patients with diabetes.
- Anemia, diabetes, and chronic kidney disease.
- Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes.
- Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.
- ATLANTIC DIP: pregnancy outcome for women with pregestational diabetes along the Irish Atlantic seaboard.
- Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward.
- Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.
- Novel noninvasive breath test method for screening individuals at risk for diabetes: response to Dillon et al.
- Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels: response to Utzschneider et al.
- Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires.
- Pioglitazone-induced acute rhabdomyolysis.
- Bone disease, gestational diabetes mellitus, and health care.
- Prevention of diabetes self-management program (PREDIAS): effects on weight, metabolic risk factors, and behavioral outcomes.
- Low HDL cholesterol is associated with the risk of stroke in elderly diabetic individuals: changes in the risk for atherosclerotic diseases at various ages.
- International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.
- Oxidative stress and insulin resistance: the coronary artery risk development in young adults study.
- Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
- Abdominal visceral adiposity in the first trimester predicts glucose intolerance in later pregnancy.
- TRIB3 functional Q84R polymorphism is a risk factor for metabolic syndrome and carotid atherosclerosis.
- Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit.
- Reference values for continuous glucose monitoring in Chinese subjects.
- Association of smoking status, weight change, and incident metabolic syndrome in men: a 3-year follow-up study.
- Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes.
- Adiponectin and lipoprotein particle size.
- Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes.
- Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial.
- Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals.
- Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.
- Automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients.
- The second-meal phenomenon in type 2 diabetes.
- Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.
- Costs to Medicare of the Informatics for Diabetes Education and Telemedicine (IDEATel) home telemedicine demonstration: findings from an independent evaluation.
- Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.
- Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study.
- Cognition in the early stage of type 2 diabetes.
- Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men.
- Secular trends in diabetes-related preventable hospitalizations in the United States, 1998-2006.
- Ranirestat for the management of diabetic sensorimotor polyneuropathy.
- Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile.
- Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study.
- Male predominance of congenital malformations in infants of women with type 1 diabetes.
- Central processing of gut pain in diabetic patients with gastrointestinal symptoms.
- Diabetes quality of care and outpatient utilization associated with electronic patient-provider messaging: a cross-sectional analysis.
- Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin.
- Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study.
- Association of 20-year changes in cardiorespiratory fitness with incident type 2 diabetes: the coronary artery risk development in young adults (CARDIA) fitness study.
- Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).
- Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes.
